Andy Arno

Jul 15, 2015

OncoCyte has appointed Andy Arno to its board of directors. Currently vice chairman of "The Special Equities Group" at Chardan Capital Markets, Arno has more than 30 years of capital markets experience working with emerging growth firms. His past experience includes being managing director of investment bank Emerging Growth Equities, and vice president of Sabr, as well as president of LOMUSA.